The Research and Development team at Axol Bioscience focuses on advancing innovative cell culture techniques and developing high-quality primary and iPSC-derived cells. This team conducts cutting-edge research, optimizes growth media, and collaborates on gene editing projects to enhance the functional utility of cells for applications in drug discovery and toxicology. Their efforts ensure that Axol maintains its position as a leader in providing disease-relevant cell models to the scientific community.
View all